Font Size: a A A
Keyword [selective inhibitor]
Result: 21 - 40 | Page: 2 of 3
21. Effects Of Cyclooxygenase-2 Selective Inhibitor NS-398 On Apoptosis And Expression Of Inhibitor Of Apoptosis Proteins In Hepatocellular Carcinoma BEL-7402 And HepG2 Cell Lines
22. Synergistic Effect Of COX-2 Selective Inhibitor Combined With DDP On Esophageal Cancer Cells
23. Survival Of Transplanted Cells In Infracted Myocardium And Heart Function By Invention Of Nitric Oxide Synthase In Rat
24. Selective Inhibitor Of Cathepsin K Design, Synthesis And Screening
25. Aurora Kinase B Selective Inhibitor Azd1152 Treatment Of Acute Leukemia In Experimental Research
26. Effects Of Cyclooxygenase Inhibitors On Survival Time In Xenograft-bearing Ovarian Cancer Mice
27. Anovel Gstm Inhibitor Rescue The Sensitivity Of Human Ovary Cancer Cells To Ddp And The Underlying Mechnism Study
28. Pharmacokinetics Studies Of Selective PDE10A Inhibitor PR-1346, As A Novel Therapy For Schizophrenia
29. The Administration Of Selective COX-2Inhibitor In The Treatment Of Perioperative Pain After Orthopadeic Surgery
30. Killing Effect Of Bcl-2 Selective Inhibitor ABT-199 In Combination With Carboplatin In Non-small Cell Lung Cancer Cell Line A549
31. NS-398 Reverses Multi-drug Resistance Effects Of Colorectal Carcinoma Cells
32. Antitumor Effect Of Brd4 Selective Inhibitor JQ1 On Glioblastoma
33. Design, Synthesis And Antitumor Activity Evaluation Of Plk1 Inhibitors
34. The Effect Of NS-398 On Apoptosis And Expression Of Associated Molecules Of Human Colorectal Carcinoma HCT-8 Cell
35. Synergistic Anti-cancer Interactions Between LY2603618,a CHK1 Selective Inhibitor,and Gemcitabine In Human Pancreatic Cancer Cells
36. GSTM Isozyme-selective Inhibitor Sensitize Resistant Cancer Cells To Cisplatin In Vitro And In Vivo
37. Activity And Mechanism Of Action Of The Novel Bcl-2 Selective Inhibitor ABT-199 In Acute Myeloid Leukemia
38. Amlexanox,a Selective Inhibitor Of IKBKE,Inhibits Human Glioblastoma By Disrupting The Hippo Pathway
39. Anti-tumor Mechanism And Combined Therapies Of SPHK2 Selective Inhibitor In Cholangiocarcinoma
40. Development And Mechanistic Studies Of Novel Therapeutics Towards Pancreatic Ductal Adenocarcinoma By Combining PI3K,mTOR And ERK Inhibitors,or Targeting One-carbon Metabolism
  <<First  <Prev  Next>  Last>>  Jump to